Welcome to CDC Stacks | The Concentration of Opioid Prescriptions by Providers and Patients in the Oregon Medicaid Program - 39937 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The Concentration of Opioid Prescriptions by Providers and Patients in the Oregon Medicaid Program
Filetype[PDF - 204.04 KB]


Details:
  • Pubmed ID:
    26766755
  • Pubmed Central ID:
    PMC4912042
  • Description:
    Objective

    This study seeks to understand the distribution of opioid prescribing across providers and patients, and examines how this concentration predicts opioid misuse.

    Methods

    Using 2013 Oregon Medicaid claims and National Provider ID registry, this study identified patients who filled at least one opioid prescription and providers who prescribed opioids for those patients (N=61,477 Medicaid patients). This study examined the distribution of opioid prescriptions by provider and patient, the extent to which high-volume opioid use was associated with potential opioid misuse, and how this association changes when patients received opioids from providers in the top decile of morphine equivalents (MEQ) prescribed in 2013. This study used four indicators of opioid misuse: doctor and pharmacy shopping for opioid prescriptions, opioid prescription overlap, and opioid and benzodiazepine prescription overlap.

    Results

    Opioid use and prescriptions were heavily concentrated among the top 10% opioid users and prescribers. Those high-volume opioid users and prescribers accounted for 83.2% and 80.8% in MEQ of entire opioids prescribed. Patients’ increasing use of MEQ was associated with most measures of opioid misuse. Patients receiving opioids from high-volume prescribers had a higher probability of opioid prescription overlap and opioid and benzodiazepine prescription overlap, but the increase was significant only among patients who received high doses of opioids and the size of the increase was modest.

    Conclusions

    Whereas current policies emphasize reducing opioid prescriptions across all patients and providers, study results suggest potential for policies that focus on high-volume opioid users and prescribers.

  • Document Type:
  • Collection(s):
  • Funding:
    UG1 DA015815/DA/NIDA NIH HHS/United States
    R33 DA035640/DA/NIDA NIH HHS/United States
    U01 CE002500/CE/NCIPC CDC HHS/United States
    R01 DA 030431/DA/NIDA NIH HHS/United States
    P50 DA018165/DA/NIDA NIH HHS/United States
    R01 DA030431/DA/NIDA NIH HHS/United States
    R01MH1000001/MH/NIMH NIH HHS/United States
    R01 MH100001/MH/NIMH NIH HHS/United States
    R33DA035640,/DA/NIDA NIH HHS/United States
    R01 DA029716/DA/NIDA NIH HHS/United States
No Related Documents.
You May Also Like: